The Human Upgrade: Biohacking for Longevity & Performance

Viruses: The Ultimate Gene Therapy Machines – Liz Parrish : 682

7 snips
Mar 31, 2020
Liz Parrish, Founder and CEO of BioViva Sciences, is pioneering the use of gene therapy to extend healthy lifespans. She shares her experience as the first person to undergo dual gene therapies for aging and discusses how viruses can act as effective delivery systems for genes. The conversation dives into the ethical challenges of genetic engineering, the role of mitochondria in aging, and the potential of gene therapies to replace traditional medicine. With insights on enhancing athletic performance and the future of biohacking, it's a glimpse into the cutting edge of medical science.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
ANECDOTE

Liz Parrish's Path to Gene Therapy

  • Liz Parrish became interested in regenerative medicine while volunteering for stem cell advocacy.
  • Her son's type 1 diabetes diagnosis in 2013 fueled her pursuit of translating research into accessible treatments.
INSIGHT

Targeting Aging for Wider Impact

  • Biological aging is the biggest unmet medical need, encompassing various childhood diseases.
  • Addressing aging expedites cures for these diseases, leading to optimal human homeostasis.
INSIGHT

Gap Between Research and Treatment

  • Academic research often concludes with "more research is needed", hindering translation to patients.
  • Doctors face a dilemma: adhering to the Hippocratic Oath or using potentially effective but unproven therapies.
Get the Snipd Podcast app to discover more snips from this episode
Get the app